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Microtubule Stabilizing Agents (MSA) are one of the most successful 
antitumour drugs used in clinical treatment of neoplasic diseases. These compounds 
mimic the paclitaxel mechanism of action, which preferentially binds to microtubules 
the assembled form of tubulin, displacing the assembly equilibrium between dimeric and 
polymeric tubulin. Since this assembly and disassembly equilibrium is essential to cell 
division, compounds that bind tubulin target rapidly dividing cells (as tumoural ones), 
arresting them in mitosis, and finally killing them through apoptosis.  
The screening of compounds with a similar mechanism of action as paclitaxel 
but with improved chemical (easy of synthesis) or pharmacological properties (better 
bioavailability, lower toxicity, less prone to cause resistance) lead to the searching of 
chemically different molecules with apparently the same biological mechanism of 
action.  
Zampanolide, a 20-membered macrolide from a Tongan marine sponge, and its 
synthetic derivative Dactylolide are potent new covalent MSA targeting the pore site. 
These MSA block cells in G2/M of the cell cycle, induce microtubule bundles in cells 
and present cytotoxic activity in the low nanomolar range. The advantages of these 
compounds include the amenability to large-scale synthesis and its activity in multidrug-
resistant cells, since Zampanolide and Dactylolide are not substrates for P-glycoprotein 
efflux pump.  
Using combined MS analyses based on targeted precursor ion scanning (4000 
Q-Trap) and shotgun (LTQ-Orbitrap) approaches, we determined Y-224 within the 
paclitaxel binding domain of beta-tubulin as the Zampanolide and Dactylolide 
interaction site. 
